Skip to main content

Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia

Rheumatology International volume 34, pages 1257–1261 (2014)Cite this article

Abstract

Fibromyalgia may present with widespread pain and tenderness, fatigue, anxiety, and depression and is associated with a low pain threshold. The etiology of fibromyalgia is yet to be ascertained, although both genetic and environmental factors may play a role in the susceptibility of patients to fibromyalgia. Various genetic variations have been investigated to explain fibromyalgia susceptibility and differences in pain sensitivity, pain threshold, and tolerance. The A118G rs1799971 polymorphism in the opioid receptor μ1 gene (OPRM1) is one of the candidate genes. We hypothesized that the OPRM1 polymorphism may play a role in fibromyalgia susceptibility and impact the pain intensity and pain-related symptoms in fibromyalgia patients. This study comprised of 108 patients with fibromyalgia and 100 healthy controls. Overall, the 118G allele frequency was 16.3 % and was significantly lower in patients with fibromyalgia than in the control group (13.9 and 19 %, respectively). No difference was observed between fibromyalgia patients with and without the A118G allele with regard to the Beck Depression Inventory, widespread pain index, symptom severity, and Fibromyalgia Impact Questionnaire scores. All body parts of patients with fibromyalgia demonstrated lower pressure pain thresholds (PPT) compared to controls. The PPTs were higher in the 118 A/A genotype carrier fibromyalgia patients than in 118*/G carriers; however, the differences were not significant. As the A118G polymorphism frequency was lower in fibromyalgia patients, this polymorphism may exert a protective effect against fibromyalgia in Turkish women. However, the OPRM1 polymorphism does not have a significant effect on pressure pain and fibromyalgia severity.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172

    CAS  PubMed  Article  Google Scholar 

  2. Martínez-Jauand M, Sitges C, Rodríguez V, Picornell A, Ramon M, Buskila D, Montoya P (2013) Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene. Eur J Pain 17:16–27

    PubMed  Article  Google Scholar 

  3. Bradley LA (2009) Pathophysiology of fibromyalgia. Am J Med 122:22–30

    Article  Google Scholar 

  4. Buskila D, Sarzi-Puttini P, Ablin JN (2007) The genetics of fibromyalgia syndrome. Pharmacogenomics 8:67–74

    CAS  PubMed  Article  Google Scholar 

  5. Tander B, Gunes S, Boke O, Alayli G, Kara N, Bagci H, Cantürk F (2008) Polymorphisms of the serotonin-2A receptor and catechol-Omethyltransferase genes: a study on fibromyalgia susceptibility. Rheumatol Int 28:685–691

    CAS  PubMed  Article  Google Scholar 

  6. Barbosa FR, Matsuda JB, Mazucato M, de Castro França S, Zingaretti SM, da Silva LM (2012) Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients. Rheumatol Int 32:427–430

    CAS  PubMed  Article  Google Scholar 

  7. Finan PH, Zautra AJ, Davis MC, Lemery-Chalfant K (2010) Genetic influences on the dynamics of the pain and affect in fibromyalgia. Health Psychol 29:134–142

    PubMed Central  PubMed  Article  Google Scholar 

  8. Lee YH, Choi SJ, Ji JD (2012) Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol Int 32:417–426

    CAS  PubMed  Article  Google Scholar 

  9. Gracely RH, Petzke F, Wolf JM, Clauw DJ (2002) Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46:1333–1343

    PubMed  Article  Google Scholar 

  10. Umeda M, Corbin LW, Maluf KS (2013) Preliminary investigation of absent nociceptive flexion reflex responses among more symptomatic women with fibromyalgia syndrome. Rheumatol Int 33:2365–2372

    PubMed  Article  Google Scholar 

  11. Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K, Tchivileva IE, Belfer I, Mishra B, Kiselycznyk C, Wallace MR, Staud R, Spiridonov NA, Max MB, Goldman D, Fillingim RB, Maixner W, Diatchenko L (2009) Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet 18:1037–1051

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  12. Pasternak GW (2010) Molecular insights into mu opioid pharmacology: from the clinic to the bench. Clin J Pain 26(Suppl 10):S3–S9

    PubMed Central  PubMed  Article  Google Scholar 

  13. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM, Tischfield JA, Kreek MJ, Yu L (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 95:9608–9613

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  14. Beyer A, Koch T, Schröder H, Schulz S, Höllt V (2004) Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem 89:553–560

    CAS  PubMed  Article  Google Scholar 

  15. Zubieta JK, Dannals RF, Frost JJ (1999) Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry 156:842–848

    CAS  PubMed  Google Scholar 

  16. Mura E, Govoni S, Racchi M, Carossa V, Ranzani GN, Allegri M, van Schaik RH (2013) Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside? J Pain Res. 6:331–353

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  17. Olsen MB, Jacobsen LM, Schistad EI, Pedersen LM, Rygh LJ, Røe C, Gjerstad J (2012) Pain intensity the first year after lumbar disc herniation is associated with the A118G polymorphism in the opioid Receptor Mu 1 gene: evidence of a sex and genotype interaction. J Neurosci 32(29):9831–9834

    CAS  PubMed  Article  Google Scholar 

  18. Walter C, Lötsch J (2009) Meta-analysis of the relevance of the OPRM1 118A. G genetic variant for pain treatment. Pain 146:270–275

    CAS  PubMed  Article  Google Scholar 

  19. Fillingim RB, Kaplan L, Staud R, Ness TJ, Glover TL, Campbell CM, Mogil JS, Wallace MR (2005) The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain 6:159–167

    CAS  PubMed  Article  Google Scholar 

  20. Sia AT, Lim Y, Lim EC, Goh RW, Law HY, Landau R, Teo YY, Tan EC (2008) A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology 109:520–526

    CAS  PubMed  Article  Google Scholar 

  21. Chong RY, Oswald L, Yang X, Uhart M, Lin P-I, Swan GS (2006) The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. Neuropsychopharmacology 31:204–211

    CAS  PubMed  Google Scholar 

  22. Bart G, LaForge KS, Borg L, Lily C, Ho A, Kreek MJ (2006) Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor gene. Neuropsychopharmacology 31:204–211

    Google Scholar 

  23. Katedoff D, Kosek E (2010) Evidence of reduced sympatho-adrenal and hypothalamic-pituitary activity during static muscular work in patients with fibromyalgia. J Rehabil Med 42:765–772

    Article  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Afyon Kocatepe University, Afyon, Turkey

    Özlem Solak, Alper Murat Ulaşlı, Fatima Yaman & Ümit Dündar

  2. Department of Medical Genetics, Faculty of Medicine, Afyon Kocatepe University, Afyon, Turkey

    Müjgan Özdemir Erdoğan, Handan Yıldız, Evrim Suna Arıkan Terzi & Mustafa Solak

  3. Department of Internal Medicine, Faculty of Medicine, Afyon Kocatepe University, Afyon, Turkey

    Sena Ulu

Authors
  1. Özlem Solak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Müjgan Özdemir Erdoğan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Handan Yıldız
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alper Murat Ulaşlı
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fatima Yaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Evrim Suna Arıkan Terzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sena Ulu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ümit Dündar
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mustafa Solak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alper Murat Ulaşlı.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Solak, Ö., Erdoğan, M.Ö., Yıldız, H. et al. Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia. Rheumatol Int 34, 1257–1261 (2014). https://doi.org/10.1007/s00296-014-2995-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-014-2995-1

Keywords

  • Fibromyalgia
  • Genetics
  • OPRM1 polymorphism
  • Pain